GERM
Amplify Treatments, Testing and Advancements ETF
GERM
GERM
Delisted
GERM was delisted on the 5th of September, 2024.
25 hedge funds and large institutions have $5.14M invested in Amplify Treatments, Testing and Advancements ETF in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$482K | |
| 2 | +$64.4K | |
| 3 | +$38.2K | |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$11.5K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$5.43K |
Top Sellers
| 1 | -$1.06M | |
| 2 | -$37.5K | |
| 3 | -$30.8K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$28.5K |
| 5 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$26.9K |